Literature DB >> 18036745

[Pathophysiology of preeclampsia].

V Tsatsaris1, T Fournier, N Winer.   

Abstract

Preeclampsia is a human disease, usually occurring during the third trimester of pregnancy. The underlying pathogenetic mechanisms of preeclampsia are much debated. Current hypotheses include placental dysfunction, inflammatory disease, genetic predisposition and immune maladaptation. Recent studies highlight the role of vascular-mediated factors in the pathophysiology of preeclampsia and allow new hopes for screening and therapeutic approaches. This article describes pathophysiological mechanisms involved in the defective uteroplacental vascularization leading to placental and endothelial dysfunction.

Entities:  

Mesh:

Year:  2007        PMID: 18036745     DOI: 10.1016/j.jgyn.2007.08.003

Source DB:  PubMed          Journal:  J Gynecol Obstet Biol Reprod (Paris)        ISSN: 0150-9918


  3 in total

1.  In vivo MRI assessment of placental and foetal oxygenation changes in a rat model of growth restriction using blood oxygen level-dependent (BOLD) magnetic resonance imaging.

Authors:  S Aimot-Macron; L J Salomon; B Deloison; R Thiam; C A Cuenod; O Clement; N Siauve
Journal:  Eur Radiol       Date:  2013-02-26       Impact factor: 5.315

2.  Risk factors for eclampsia in pregnant women with preeclampsia and positive neurosensory signs.

Authors:  Houssam Rebahi; Megan Elizabeth Still; Yassine Faouzi; Ahmed Rhassane El Adib
Journal:  Turk J Obstet Gynecol       Date:  2019-01-09

3.  Reduced placental telomere length during pregnancies complicated by intrauterine growth restriction.

Authors:  Jérôme Toutain; Martina Prochazkova-Carlotti; David Cappellen; Ana Jarne; Edith Chevret; Jacky Ferrer; Yamina Idrissi; Fanny Pelluard; Dominique Carles; Brigitte Maugey-Laulon; Didier Lacombe; Jacques Horovitz; Jean-Philippe Merlio; Robert Saura
Journal:  PLoS One       Date:  2013-01-11       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.